Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Neurorehabilitation|July 9, 2026
Incomplete Cognitive Assessment in Post-Acute Stroke Rehabilitation: Recovering Clinically Interpretable Relationships from Routine Neuropsychological DataAlejandro García-Rudolph, Rocío Sánchez-Carrión, Katryna Cisek, et al.
Plos Computational Biology|June 26, 2019
Model-inferred mechanisms of liver function from magnetic resonance imaging data: Validation and variation across a clinically relevant cohortMikael F Forsgren, Markus Karlsson, Olof Dahlqvist Leinhard, et al.
Interface Focus|April 7, 2016
Requirements for multi-level systems pharmacology models to reach end-usage: the case of type 2 diabetesElin Nyman, Yvonne J W Rozendaal, Gabriel Helmlinger, et al.
Nature Metabolism|August 29, 2024
Global 13C tracing and metabolic flux analysis of intact human liver tissue ex vivoNina Grankvist, Cecilia Jönsson, Karin Hedin, et al.
BMC Systems Biology|June 6, 2009
Computational disease modeling - fact or fiction?Jesper N Tegnér, Albert Compte, Charles Auffray, et al.
Scandinavian Journal of Gastroenterology|July 21, 2020
Biomarkers of liver fibrosis: prospective comparison of multimodal magnetic resonance, serum algorithms and transient elastographyMikael F Forsgren, Patrik Nasr, Markus Karlsson, et al.
The Journal of Physiology|July 24, 2023
Haemodynamic effects of hypertension and type 2 diabetes: Insights from a 4D flow MRI-based personalized cardiovascular mathematical modelKajsa Tunedal, Federica Viola, Belén Casas Garcia, et al.
BMC Gastroenterology|April 21, 2021
Evaluating the prevalence and severity of NAFLD in primary care: the EPSONIP study protocolPatrik Nasr, Fredrik Iredahl, Nils Dahlström, et al.
Plos Computational Biology|June 23, 2017
LASSIM-A network inference toolbox for genome-wide mechanistic modelingRasmus Magnusson, Guido Pio Mariotti, Mattias Köpsén, et al.
BMC Gastroenterology|December 22, 2023
A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocolPatrik Nasr, Mikael Forsgren, Wile Balkhed, et al.
Pageof 8